Discover 2,356 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,356
Active & Responsive
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Orange CA, Redwood City CA, Seattle WA, Kansas City MO,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Sex: All
Age: 0 - 70+
Code: NCT05500807
Phase 1, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Fountain Valley CA, Los Angeles CA, Northridge CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Active & Responsive
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
for
Pain
Location: Riverside CA, Phoenix AZ, Salt Lake City UT,
Sponsor: Adneuris Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07845071
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
for
Moderate to Severe Psoriatic Arthritis
Location: Huntington Beach CA, San Antonio TX, Colleyville TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07801495
Phase 2, Recruiting
Active & Responsive
Pivotal Study of the Velocity™ pAVF System
for
Chronic Kidney Disease, Hemodialysis Access,
Location: Riverside CA, San Antonio TX, Concord CA, Houston TX,
Sponsor: Venova Medical
Sex: All
Age: 18 - 70+
Code: NCT07153939
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Orange CA, Phoenix AZ, San Francisco CA, Dallas TX,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase 2, Recruiting
Active & Responsive
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
for
IGF1 Deficiency
Location: Orange CA, Cincinnati OH, Miami FL
Sponsor: Esteve Pharmaceuticals, S.A.
Sex: All
Age: 2 - 18
Code: NCT00903110
Recruiting
Active & Responsive
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
for
Epileptic Encephalopathy
Location: Orange CA, Columbus OH, Boston MA
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 2 - 12
Code: NCT07227857
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
for
Pediatric Tumor of CNS, Pediatric Tumor of Brain,
Location: Orange CA
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 5 - 18
Code: NCT06357377
Phase 1, Recruiting
Active & Responsive
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
for
Age-Related Macular Degeneration
Location: Riverside CA, Los Angeles CA, Palo Alto CA, Portland OR,
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 50+
Code: NCT03178149
Phase 1, Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Orange CA, Houston TX, Flowood MS, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase 3, Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Orange CA, Rancho Mirage CA, Sylmar CA, Fresno CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: Orange CA, Riverside CA, Anaheim CA, Garden Grove CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06929273
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
for
Mania, Bipolar Disorder
Location: Orange CA, Riverside CA, Chino CA, La Habra CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07140913
Phase 3, Recruiting
Active & Responsive
Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)
for
Autism Spectrum Disorder (ASD)
Location: Orange CA, Baltimore MD
Sponsor: Children's Hospital of Orange County
Sex: Male
Age: 5 - 14
Code: NCT06866275
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Orange CA, Garden Grove CA, Redlands CA, Las Vegas NV,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase 3, Recruiting
Active & Responsive
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
for
Esophageal Carcinoma, Gastric Cancer (Diagnosis),
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT07795749
Phase 2, Recruiting
Active & Responsive
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
for
Ovarian Cancer, Cognitive Impairment
Location: Orange CA
Sponsor: University of California, Irvine
Sex: Female
Age: 18+
Code: NCT04520139
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)